Steven Cohen's position in Abivax is currently worth $61.6M. That's 0.10% of their equity portfolio (236th largest holding). The first Abivax trade was made in Q4 2023. Since then Steven Cohen bought shares five more times and sold shares on four occasions. The stake costed the investor $32.3M, netting the investor a gain of 90% so far.